Literature DB >> 21214533

Epilepsy as a spectrum disorder: Implications from novel clinical and basic neuroscience.

Frances E Jensen1.   

Abstract

Epilepsy is increasingly recognized as a disease that reaches well beyond seizures. Cognitive and psychiatric impairment affect half of all epilepsy patients, and to date there are no specific treatments for these symptoms. It is unclear which of these comorbidities are directly due to seizures and which are due to separable mechanisms that are parallel to those underlying ictal activity. Cellular and molecular mechanisms underlying synaptic modulation are central to both the ictal and nonictal changes in epilepsy. Current diagnostic methods are rapidly advancing to better delineate the nature and extent of ictal activity, and could soon be critical in identifying patterns unique to the cognitive and psychiatric comorbidities. Wiley Periodicals, Inc.
© 2011 International League Against Epilepsy.

Entities:  

Mesh:

Year:  2011        PMID: 21214533     DOI: 10.1111/j.1528-1167.2010.02904.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  46 in total

Review 1.  Brain inflammation as a biomarker in epilepsy.

Authors:  Annamaria Vezzani; Alon Friedman
Journal:  Biomark Med       Date:  2011-10       Impact factor: 2.851

Review 2.  Depression in epilepsy: a critical review from a clinical perspective.

Authors:  Christian Hoppe; Christian E Elger
Journal:  Nat Rev Neurol       Date:  2011-07-12       Impact factor: 42.937

Review 3.  Comorbidities in Neurology: Is adenosine the common link?

Authors:  Detlev Boison; Eleonora Aronica
Journal:  Neuropharmacology       Date:  2015-05-13       Impact factor: 5.250

4.  Evidence for a shared genetic susceptibility to migraine and epilepsy.

Authors:  Melodie R Winawer; Robert Connors
Journal:  Epilepsia       Date:  2013-01-07       Impact factor: 5.864

5.  Antiseizure drugs differentially modulate θ-burst induced long-term potentiation in C57BL/6 mice.

Authors:  Peter J West; Gerald W Saunders; Gregory J Remigio; Karen S Wilcox; H Steve White
Journal:  Epilepsia       Date:  2014-01-21       Impact factor: 5.864

Review 6.  Methods and utility of EEG-fMRI in epilepsy.

Authors:  Louis André van Graan; Louis Lemieux; Umair Javaid Chaudhary
Journal:  Quant Imaging Med Surg       Date:  2015-04

Review 7.  Neuroimaging biomarkers of preterm brain injury: toward developing the preterm connectome.

Authors:  Ashok Panigrahy; Jessica L Wisnowski; Andre Furtado; Natasha Lepore; Lisa Paquette; Stefan Bluml
Journal:  Pediatr Radiol       Date:  2012-03-06

Review 8.  Hyperphosphorylated tau is implicated in acquired epilepsy and neuropsychiatric comorbidities.

Authors:  Ping Zheng; Sandy R Shultz; Chris M Hovens; Dennis Velakoulis; Nigel C Jones; Terence J O'Brien
Journal:  Mol Neurobiol       Date:  2013-12-10       Impact factor: 5.590

9.  Epilepsy among children and adolescents with autism spectrum disorders: a population-based study.

Authors:  Elina Jokiranta; Andre Sourander; Auli Suominen; Laura Timonen-Soivio; Alan S Brown; Matti Sillanpää
Journal:  J Autism Dev Disord       Date:  2014-10

10.  Glutamate receptor 1 phosphorylation at serine 831 and 845 modulates seizure susceptibility and hippocampal hyperexcitability after early life seizures.

Authors:  Sanjay N Rakhade; Erin F Fitzgerald; Peter M Klein; Chengwen Zhou; Hongyu Sun; Richard L Huganir; Richard L Hunganir; Frances E Jensen
Journal:  J Neurosci       Date:  2012-12-05       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.